ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Liver Kinase B1 in CD11c
Wenqing Zhang, Shan Guo, Yu Zhang, He Ren, Ke Lei, Chenyang Zhao, Qian Yu, Hongqing Luo, Yujing Xiao, Xiaoming Feng and 1 more
Abstract read
In one paragraphArticle in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Wenqing ZhangDepartment of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Shan GuoDepartment of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yu ZhangDepartment of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China.
He RenGastrointestinal Cancer Institute (Pancreatic Disease Institute), the Affiliated Hospital of Qingdao University, Qingdao, China.
Ke LeiTumor Immunology and Cytotherapy of Medical Research Center, Key Laboratory of Pancreatic Disease Clinical Research (Shandong Province), the Affiliated Hospital of Qingdao University, Qingdao, China.
Chenyang ZhaoTumor Immunology and Cytotherapy of Medical Research Center, Key Laboratory of Pancreatic Disease Clinical Research (Shandong Province), the Affiliated Hospital of Qingdao University, Qingdao, China.
Qian YuTumor Immunology and Cytotherapy of Medical Research Center, Key Laboratory of Pancreatic Disease Clinical Research (Shandong Province), the Affiliated Hospital of Qingdao University, Qingdao, China.
Hongqing LuoDepartment of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yujing XiaoDepartment of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Funding
2023 Qingdao Technology Benefiting Demonstration Project 23-2-8-smjk-8-nshKey Program of National Natural Science Foundation of China 82330081"Medicine Plus " Joint Research Program of Qingdao University YX2024201National Science Fund for Distinguished Young Scholars 82125026Natural Science Foundation of China 82270676Taishan Young Scholars Program of Shandong Province tsqn202306395
6 · The paper itselfAbstract
Chronic pancreatitis (CP), characterized by irreversible fibrosis, is a high-risk factor for pancreatic cancer. Current therapeutic strategies remain inadequate. This study identified a significant increase in CD11c
Indexed as
CD11c AntigenFibrosisOncostatin MPancreatitis, ChronicProtein Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesAMP-Activated Protein KinasesAnimalsDisease Models, AnimalHumansMacrophagesMaleMicePancreasPancreatic Stellate CellsSignal TransductionAMP-Activated Protein Kinase KinasesAMP-Activated Protein KinasesCD11c AntigenOncostatin MProtein Serine-Threonine KinasesStk11 protein, mouseCCL2/CCR2chronic pancreatitisfibrosisliver kinase B1oncostatin M
Identifiers
PMID41910173
PMCPMC13252620
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390